---
title: "China Resources Pharmaceutical Completes RMB 800 Million Medium-Term Note Issuance"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302856714.md"
description: "China Resources Pharmaceutical completed the issuance of RMB 800 million in third-tranche medium-term notes on October 23, 2026. The wholly owned subsidiary issued three-year notes with a 1.45% annual coupon. Net proceeds will be used to repay interest-bearing debt and fund other purposes permitted by law."
datetime: "2026-10-23T09:46:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302856714.md)
  - [en](https://longbridge.com/en/news/302856714.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302856714.md)
generator: "portal-rs"
---

# China Resources Pharmaceutical Completes RMB 800 Million Medium-Term Note Issuance

-   China Resources Pharmaceutical completes RMB 800 million third-tranche medium term notes issuance on Oct. 23, 2026. \* Wholly owned subsidiary China Resources Pharmaceutical Holdings issued the three-year notes at a 1.45% annual coupon. \* Net proceeds will repay interest-bearing debt and fund other purposes permitted under applicable laws and regulations. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261023-12381437), on October 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [03320.HK](https://longbridge.com/en/quote/03320.HK.md)
- [01508.HK](https://longbridge.com/en/quote/01508.HK.md)

## Related News & Research

- [China Resources Pharmaceutical Unit Secures Approval for RMB 10 Billion Corporate Bond Issuance](https://longbridge.com/en/news/305661943.md)
- [China Resources Pharmaceutical Group Subsidiary CR Pharmaceutical Commercial’s Nine-Month Net Profit Rises to RMB 1.75 Billion](https://longbridge.com/en/news/303715107.md)
- [The bank of Nvidia is getting more ‘disciplined,’ selective](https://longbridge.com/en/news/306148745.md)
- [NetEase Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into NetEase (NTES)](https://longbridge.com/en/news/306200520.md)
- [Moonshot drops $150M Indonesia Nvidia rental days after US loophole crackdown](https://longbridge.com/en/news/306145817.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**